PsychPlus Las Cruces Clinic - Psychiatrist and Therapist
2300 North Main Street, Suite 209, Las Cruces
3.0(4 Google reviews)
United States
1 listed treatment center serving Las Cruces and the surrounding area.
2300 North Main Street, Suite 209, Las Cruces
3.0(4 Google reviews)
The cost of SPRAVATO® treatment in Las Cruces depends on your insurance benefits, the treatment setting, and the care you receive. Ask for an estimate that separates the medication from the supervised treatment visit. Both the nasal spray and the observation and monitoring services may be billed, so a medication benefit check alone may not explain your full out-of-pocket responsibility.
Many plans require prior authorization before treatment begins. The center may need records of earlier antidepressant trials, including which medications you took, how long you took them, and your response. Ask your current prescriber to help gather these records. Authorization is not a guarantee that every charge will be paid.
Medicare and New Mexico Medicaid may cover treatment, but coverage depends on the plan and setting. Medicare coverage may fall under Part B or Part D. Confirm how your benefits apply rather than assuming that a center's participation means every service is covered.
Manufacturer savings programs exist for eligible commercially insured patients; they are not available for patients using government insurance. Eligibility rules apply, and savings may not cover every visit-related charge.
Before starting, ask the center and insurer:
Request written benefit information and an individualized estimate when available.
This directory currently has no listed treatment center in Las Cruces. It also has no listed centers in other New Mexico cities to suggest nearby. That is a limitation of the directory, not proof that care is unavailable. Ask your prescribing clinician or insurer to help locate a SPRAVATO® REMS-certified healthcare setting, then confirm certification and appointment availability directly before making travel plans.
Spravato is never taken home. You self-administer the nasal spray under direct observation of a healthcare provider at a certified setting. Monitoring lasts at least two hours after each dose, and check-in, assessment, and discharge steps can make the total appointment longer. Ask how much time to reserve rather than assuming you can leave exactly two hours after arrival.
For treatment-resistant depression, the typical labeled schedule starts twice weekly during weeks 1–4, then weekly during weeks 5–8. Later visits may be weekly or every two weeks. Your prescriber individualizes the schedule; do not assume a fixed long-term routine.
Arrange for someone else to drive you home after every treatment. You must not drive or operate machinery until the next day after a restful sleep. If using a hired ride, ask the center whether an accompanying adult is required under its discharge policy. Have a backup plan if your usual driver cancels.
When planning time off work, account for travel, the full appointment, and recovery afterward. Discuss scheduling needs, especially if your job involves driving or machinery. Arrange childcare or other responsibilities ahead of time so you do not need to rush home.
This directory currently has no listed SPRAVATO® treatment center in Las Cruces and no other listed New Mexico cities to recommend. Ask your clinician or insurer for help finding a setting that participates in the Spravato REMS program. Confirm certification, whether new patients are accepted, and insurance participation directly. A directory listing alone does not establish certification.
Spravato is approved for adults with treatment-resistant depression, alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must assess your diagnosis, treatment history, medical risks, and whether it is appropriate for you.
Coverage depends on your plan and treatment setting. Prior authorization and records of earlier antidepressant trials are commonly required. Ask about both the medication and the supervised monitoring visit, since these may be billed separately. Medicare and New Mexico Medicaid may provide coverage depending on the plan and setting. Confirm benefits and expected out-of-pocket responsibilities before starting.
You use the nasal spray yourself under a healthcare provider's direct observation in a REMS-certified setting. Staff monitor you for at least two hours after dosing, including checks for sedation, dissociation, breathing problems, and blood pressure increases. The total visit may take longer. Someone else must drive you home; you cannot drive until the next day after a restful sleep.
Discuss your medical history, medications, and any history of substance misuse. Spravato has boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It can also increase blood pressure and is a Schedule III controlled substance. Ask how the team assesses these risks, monitors you, and decides when you can safely leave.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when needed. Do not wait for a treatment appointment if you need urgent help. Call or text 988 for crisis support, or call 911 in an emergency or when there is immediate danger.
Approved uses, nearby treatment centers, and medically sourced patient guides.